Hypertension and glomerular sclerosis: where, when and how?
el Nahas
A M
AM
Department of Renal Medicine, Northern General Hospital, Sheffield, UK.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000473:pathology; D004044:Dietary Proteins / Q000008:administration & dosage; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology* / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D007674:Kidney Diseases / Q000150:complications; D007678:Kidney Glomerulus / Q000098:blood supply / Q000473:pathology*; D008833:Microcirculation; D051381:Rats; D011918:Rats, Inbred SHR / Q000502:physiology; D012598:Sclerosis; D012982:Sodium, Dietary / Q000008:administration & dosage
D000959:Antihypertensive Agents; D004044:Dietary Proteins; D012982:Sodium, Dietary